Clinical Trial Update: A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

LG Chem is conducting a Phase 1 clinical trial to evaluate the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infection

Drugs mentioned

• Multivalent Pneumococcal Conjugate Vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: LG Chem | Conditions: Pneumococcal Infection | Phase 1 | Status: UNKNOWN